Backing for mass mask handout in Victoria The RACGP President has lent her support to a Victorian Government initiative to supply millions of masks at key locations around the state.
ATAGI approves Moderna vaccine for at-risk young children Parents are advised not to contact vaccine providers until bookings open, following decision to approve vaccination for the youngest cohort.
Could anticipatory deprescribing allow better COVID treatment? Despite being more effective according to some studies, Paxlovid prescriptions lag Lagevrio, with drug–drug interactions likely to play a part.
Studies focus on COVID infectious period Early research suggests a quarter of people or more may still be infectious with COVID-19 after seven days, the standard isolation period across Australia.
Push to assess COVID-19 treatment eligibility prior to infection College launches new guidelines to support GPs assessing the best approach for vulnerable patients before they test positive.
COVID vaccine safety data for children ‘extremely reassuring’ A new study tracking nearly 400,000 children aged 5–15 post-vaccination found adverse events were generally short-term and mild.
Almost one in every two Australians has had COVID-19 Survey taken from blood donors in June confirms that levels have increased exponentially since a similar study in March.
TGA green lights Nuvaxovid for 12–17-year-olds But while provisional approval has been granted, inclusion in the national program for this age group is yet to be confirmed.
Short EOI window for paediatric COVID shots Expressions of interest for the six-month to four-year-old cohort are now being accepted, but general practices only have until Friday to nominate.
DoH clarifies that expanded 80/20 rule now in place The RACGP has received confirmation that the 80/20 rule was extended to telehealth services on 1 July, despite having previously understood that it would be deferred until October.